Results from two phase II advanced lung cancer trials will be presented at the upcoming 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.
The initiation of two strategic partnerships that will provide cancer patients greater and more convenient options for completing VeriStrat testing.